With EU Regulation 2025/1466, key requirements for pharmacovigilance (PV) are changing significantly: The focus is shifting away from pure formalism towards traceability, process quality, and transparent documentation.
Pharmacovigilance, or drug safety, is a fundamental pillar that ensures the protection of public health and aims to strengthen trust in medicines. The legal background
